CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Urinary exosomal microRNA profiling in type 2 diabetes patients taking dipeptidyl peptidase-4 inhibitor compared with sulfonylurea
Nam-Jun Cho, Dae-Yeon Kim, Soon Hyo Kwon, Tae Won Ha, Hyun Kyu Kim, Man Ryul Lee, Sung Wan Chun, Samel Park, Eun-young Lee, Hyo-Wook Gil
Kidney Res Clin Pract. 2021;40(3):383-391.   Published online July 7, 2021
DOI: https://doi.org/10.23876/j.krcp.21.015

Excel Download

Urinary exosomal microRNA profiling in type 2 diabetes patients taking dipeptidyl peptidase-4 inhibitor compared with sulfonylurea
Kidney Research and Clinical Practice. 2021;40(3):383-391   Crossref logo
Link1 Link2 Link3

Treatment progression in sulfonylurea and dipeptidyl peptidase-4-inhibitor cohorts of type 2 diabetes patients on metformin
Patient Preference and Adherence. 2016;Volume 10:1539-1546   Crossref logo
Link1

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial
Diabetes, Obesity and Metabolism. 2007;9(2):194-205   Crossref logo
Link1 Link2

Efficacy, safety and dose-response relationship of teneligliptin, a dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitus
Diabetes, Obesity and Metabolism. 2013;15(9):810-818   Crossref logo
Link1 Link2

Lower Risk of Dementia in Elderly Patients Initiated on Dipeptidyl Peptidase-4 Inhibitor vs. Sulfonylurea—A Population-Based Cohort Study
Diabetes. 2018;67(Supplement 1):195-LB   Crossref logo
Link1

Combination Therapy with a Dipeptidyl peptidase-4 Inhibitor, Sulfonylurea, and Metformin Markedly Improves HbA1c Levels in Japanese Patients with Type 2 Diabetes Mellitus
Japanese Clinical Medicine. 2012;3:JCM.S8571   Crossref logo
Link1 Link2 Link3

Acute pancreatitis with dipeptidyl peptidase-4 (DPP4) inhibitor or fulminant type 1 diabetes?
Diabetes & Metabolism. 2018;44(1):95-96   Crossref logo
Link1 Link2

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor PF-734200 added to metformin in Type 2 diabetes
Diabetic Medicine. 2011;28(4):464-469   Crossref logo
Link1 Link2

New Era for Renal-Protective Therapy in Type 2 Diabetes: Better Renal Outcomes in Patients with Type 2 Diabetes Taking Sodium-Glucose Cotransporter 2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors
Endocrinology and Metabolism. 2021;36(2):339-341   Crossref logo
Link1 Link2 Link3

Incident cancer risk in dipeptidyl peptidase-4 inhibitor-treated patients with type 2 diabetes mellitus

Cancer Management and Research. 2019;Volume 11:7427-7438   Crossref logo
Link1 Link2